Related Experiment Video
Updated: Jun 14, 2025
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patients
Dirk Tomsitz1, Katrin Kerl2, Lars Einar French3
1Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
Background:
Tebentafusp is a novel treatment for patients with metastatic uveal melanoma and often causes cutaneous side effects.
Objectives:
The aim of this study was to better characterize these heterogenous cutaneous side effects.
Methods:
This prospective cohort study evaluated all patients from a tertiary hospital center who were treated with tebentafusp between January 2019 and June 2023 clinically and assessed skin biopsies histologically.
Results:
In total, 33 patients were analyzed. Skin toxicity was observed in 78.8% of patients and was classified into 5 clinical categories: (1) symmetrical erythematous patches (83.8%), (2) hemorrhagic macules (11.8%), (3) urticarial lesions (7.4%), (4) bullous lesions (1.5%), and (5) skin (8.5%) and hair depigmentation (11.4%). Histopathologic features were focal lymphocytic interface dermatitis with epidermal infiltration of CD8-positive lymphocytes. Patients with skin reactions had a significantly longer median overall survival compared to patients without any cutaneous events (34 versus 4 months, P < .001).
Limitation:
Monocentric study with a limited number of patients.
Conclusion:
Tebentafusp frequently induces cutaneous reactions. Pathogenesis is likely due to binding of tebentafusp to stimulated melanocytes in the skin, followed by infiltration and activation of lymphocytes. Development of treatment-induced skin reactions may be associated with survival benefits.
Insights
Tebentafusp treatment for metastatic uveal melanoma frequently causes skin reactions like rashes and depigmentation. These cutaneous side effects may be linked to improved patient survival.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Tebentafusp is a new treatment for metastatic uveal melanoma.
- Cutaneous side effects are common with tebentafusp therapy.
Purpose of the Study:
- To characterize the diverse skin reactions caused by tebentafusp.
- To investigate the relationship between skin reactions and patient survival.
Main Methods:
- Prospective cohort study of 33 patients treated with tebentafusp.
- Clinical assessment and histological analysis of skin biopsies.
- Evaluation of survival data in relation to skin toxicity.
Main Results:
- 78.8% of patients experienced skin toxicity, with symmetrical erythematous patches being most common.
- Histopathology revealed lymphocytic interface dermatitis with CD8+ T-cell infiltration.
- Patients with skin reactions had significantly longer median overall survival (34 vs. 4 months).
Conclusions:
- Tebentafusp commonly induces cutaneous reactions, likely involving melanocytes and lymphocytes.
- Skin reactions may indicate a positive prognostic marker for survival.
- This monocentric study has limitations due to a small patient cohort.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

